Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression? Int J Mol Sci
An Integrated Workflow to Study the Promoter-Centric Spatio-Temporal Genome Architecture in Scarce Cell Populations JOVE-J VIS EXP
Iron overload refractory to phlebotomy in a patient with type 1 hereditary hemochromatosis MED CLIN-BARCELONA
Mafosfamide, a cyclophosphamide analog, causes a proinflammatory response and increased permeability on endothelial cells in vitro BONE MARROW TRANSPL
European standard clinical practice - Key issues for the medical care of individuals with familial leukemia EUR J MED GENET
An epigenetic switch controls an alternative NR2F2 isoform that unleashes a metastatic program in melanoma Nat Commun
T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo PHARMACEUTICS